{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:25:40Z","timestamp":1791404740788,"version":"4.3.3"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T00:00:00Z","timestamp":1755993600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000245","name":"Michael Smith Health Research BC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004089","name":"Krembil Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-195977"],"award-info":[{"award-number":["PJT-195977"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-148656"],"award-info":[{"award-number":["PJT-148656"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-165967"],"award-info":[{"award-number":["PJT-165967"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000143","name":"Alzheimer Society of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000143","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.neuropharm.2025.110654","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T14:58:18Z","timestamp":1755961098000},"page":"110654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Positive allosteric modulation of M1 mAChRs with VU0486846 reverses cognitive deficits in male APPswe\/PSEN1\u0394E9 alzheimer's mice"],"prefix":"10.1016","volume":"280","author":[{"given":"Karim S.","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6058-9003","authenticated-orcid":false,"given":"Tash-Lynn L.","family":"Colson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen S.G.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9724-1975","authenticated-orcid":false,"given":"Khaled S.","family":"Abd-Elrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110654_bib2","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abd2494","article-title":"A\u03b2 oligomers induce pathophysiological mGluR5 signaling in Alzheimer's disease model mice in a sex-selective manner","volume":"13","author":"Abd-Elrahman","year":"2020","journal-title":"Sci. Signal."},{"key":"10.1016\/j.neuropharm.2025.110654_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116388","article-title":"A M1 muscarinic acetylcholine receptor-specific positive allosteric modulator VU0486846 reduces neurogliosis in female Alzheimer's mice","author":"Abd-Elrahman","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuropharm.2025.110654_bib4","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1021\/acsptsci.0c00013","article-title":"mGluR5 contribution to neuropathology in alzheimer mice is disease stage-dependent","volume":"3","author":"Abd-Elrahman","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.neuropharm.2025.110654_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aan6387","article-title":"mGluR5 antagonism increases autophagy and prevents disease progression in the zQ175 mouse model of Huntington's disease","volume":"10","author":"Abd-Elrahman","year":"2017","journal-title":"Sci. Signal."},{"key":"10.1016\/j.neuropharm.2025.110654_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13041-018-0364-9","article-title":"Autophagy is increased following either pharmacological or genetic silencing of mGluR5 signaling in Alzheimer's disease mouse models","volume":"11","author":"Abd-Elrahman","year":"2018","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neuropharm.2025.110654_bib7","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/bph.15750","article-title":"A positive allosteric modulator for the muscarinic receptor (M1 mAChR) improves pathology and cognitive deficits in female APPswe\/PSEN1\u0394E9 mice","volume":"179","author":"Abd-Elrahman","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110654_bib8","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hypothesis of geriatric memory dysfunction","volume":"217","author":"Bartus","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2025.110654_bib9","article-title":"M1 muscarinic allosteric modulators slow prion neurodegeneration and restore memory loss","author":"Bradley","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuropharm.2025.110654_bib10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41589-019-0453-9","article-title":"Biased M1-muscarinic-receptor-mutant mice inform the design of next-generation drugs","volume":"16","author":"Bradley","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neuropharm.2025.110654_bib11","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMoa2017015","article-title":"Muscarinic cholinergic receptor agonist and peripheral antagonist for schizophrenia","volume":"384","author":"Brannan","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2025.110654_bib12","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.1016\/j.cell.2021.11.001","article-title":"From structure to clinic: design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer's disease","volume":"184","author":"Brown","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2025.110654_bib13","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.neuron.2010.11.018","article-title":"Facilitation of long-term potentiation by muscarinic M(1) receptors is mediated by inhibition of SK channels","volume":"68","author":"Buchanan","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2025.110654_bib14","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.6338589","article-title":"Alzheimer's disease: a disorder of cortical cholinergic innervation","volume":"219","author":"Coyle","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2025.110654_bib15","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1523\/JNEUROSCI.6393-09.2010","article-title":"Deletion of M1 muscarinic acetylcholine receptors increases amyloid pathology in vitro and in vivo","volume":"30","author":"Davis","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110654_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abm3720","article-title":"M1 muscarinic receptor activation reduces the molecular pathology and slows the progression of prion-mediated neurodegenerative disease","volume":"15","author":"Dwomoh","year":"2022","journal-title":"Sci. Signal."},{"key":"10.1016\/j.neuropharm.2025.110654_bib17","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3233\/JAD-142208","article-title":"Systematic review of the relationship between amyloid-\u03b2 levels and measures of transgenic mouse cognitive deficit in Alzheimer's disease","volume":"44","author":"Foley","year":"2015","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.neuropharm.2025.110654_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113577","article-title":"baz-2 enhances systemic proteostasis in vivo by regulating acetylcholine metabolism","volume":"42","author":"Gallrein","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2025.110654_bib19","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bbr.2018.07.007","article-title":"Depressive- and anxiety-like phenotypes in young adult APPSwe\/PS1dE9 transgenic mice with insensitivity to chronic mild stress","volume":"353","author":"Gao","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110654_bib20","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/alz.13481","article-title":"Sex-dependent cholinergic effects on amyloid pathology: a translational study","volume":"20","author":"German-Castelan","year":"2024","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neuropharm.2025.110654_bib21","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.celrep.2016.04.077","article-title":"Chronic pharmacological mGluR5 inhibition prevents cognitive impairment and reduces pathogenesis in an alzheimer disease mouse model","volume":"15","author":"Hamilton","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2025.110654_bib22","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.0014-23.2023","article-title":"VGLUT3 deletion rescues motor deficits and neuronal loss in the zQ175 mouse model of Huntington's disease","author":"Ibrahim","year":"2023","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110654_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114427","article-title":"Optineurin deletion disrupts metabotropic glutamate receptor 5-mediated regulation of ERK1\/2, GSK3\u03b2\/ZBTB16, mTOR\/ULK1 signaling in autophagy","volume":"185","author":"Ibrahim","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110654_bib24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12264-013-1406-z","article-title":"M1 muscarinic acetylcholine receptor in Alzheimer's disease","volume":"30","author":"Jiang","year":"2014","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.neuropharm.2025.110654_bib25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1176\/appi.neuropsych.12100240","article-title":"Differences in anxiety among patients with early- versus late-onset Alzheimer's disease","volume":"26","author":"Kaiser","year":"2014","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110654_bib26","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","article-title":"The amyloid hypothesis in alzheimer disease: new insights from new therapeutics","volume":"21","author":"Karran","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2025.110654_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.neuropharm.2025.110654_bib28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00213-019-05354-5","article-title":"Rescuing the attentional performance of rats with cholinergic losses by the M1 positive allosteric modulator TAK-071","volume":"237","author":"Kucinski","year":"2020","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.neuropharm.2025.110654_bib29","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/bioinformatics\/btaa847","article-title":"Colour deconvolution: stain unmixing in histological imaging","volume":"37","author":"Landini","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neuropharm.2025.110654_bib30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/YCO.0000000000000401","article-title":"Sex differences in Alzheimer's disease","volume":"31","author":"Laws","year":"2018","journal-title":"Curr. Opin. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110654_bib31","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.neuropharm.2017.11.018","article-title":"Muscarinic receptor subtype distribution in the central nervous system and relevance to aging and Alzheimer's disease","volume":"136","author":"Lebois","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110654_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2014.01.002","article-title":"Sex differences in cognitive impairment and Alzheimer's disease","author":"Li","year":"2014","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2025.110654_bib33","doi-asserted-by":"crossref","first-page":"C1454","DOI":"10.1152\/ajpcell.00151.2007","article-title":"Distinct pathways of ERK activation by the muscarinic agonists pilocarpine and carbachol in a human salivary cell line","volume":"294","author":"Lin","year":"2008","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.neuropharm.2025.110654_bib34","doi-asserted-by":"crossref","first-page":"13805","DOI":"10.1523\/JNEUROSCI.4218-08.2008","article-title":"Amyloid pathology is associated with progressive monoaminergic neurodegeneration in a transgenic mouse model of Alzheimer's disease","volume":"28","author":"Liu","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110654_bib35","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.neuron.2024.01.024","article-title":"Mechanisms of sex differences in Alzheimer's disease","volume":"112","author":"Lopez-Lee","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2025.110654_bib36","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1176\/appi.ajp.157.5.708","article-title":"Mental and behavioral disturbances in dementia: findings from the cache county study on memory in aging","volume":"157","author":"Lyketsos","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110654_bib37","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.biopsych.2019.02.020","article-title":"M1 muscarinic receptors modulate fear-related inputs to the prefrontal cortex: implications for novel treatments of posttraumatic stress disorder","volume":"85","author":"Maksymetz","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110654_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108352","article-title":"Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease","volume":"190","author":"Marucci","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110654_bib39","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1365-2125.1999.00026.x","article-title":"Acetylcholinesterase inhibitors in Alzheimer's disease","volume":"48","author":"McGleenon","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110654_bib40","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1471-4159.2007.05147.x","article-title":"Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP\/PS1 transgenic and wild-type mice","volume":"105","author":"Minkeviciene","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2025.110654_bib41","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","article-title":"High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation","volume":"20","author":"Mucke","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110654_bib42","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3233\/JAD-2006-9S331","article-title":"Lysosomal system pathways: genes to neurodegeneration in Alzheimer's disease","volume":"9","author":"Nixon","year":"2006","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.neuropharm.2025.110654_bib43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41582-018-0116-6","article-title":"A critical appraisal of amyloid-\u03b2-targeting therapies for alzheimer disease","volume":"15","author":"Panza","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110654_bib44","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1093\/cercor\/bhab406","article-title":"Developmental age and biological sex influence muscarinic receptor function and neuron morphology within layer VI of the medial prefrontal cortex","volume":"32","author":"Patel","year":"2022","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuropharm.2025.110654_bib59","doi-asserted-by":"crossref","first-page":"740","DOI":"10.2174\/1570159X21666221207091209","article-title":"Sex, Age, and Regional Differences in CHRM1 and CHRM3 Genes Expression Levels in the Human Brain Biopsies: Potential Targets for Alzheimer\u2019s Disease-related Sleep Disturbances","volume":"21","author":"Sanfilippo","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2025.110654_bib45","doi-asserted-by":"crossref","first-page":"14271","DOI":"10.1523\/JNEUROSCI.3930-09.2009","article-title":"A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning","volume":"29","author":"Shirey","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110654_bib46","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/ageing\/afl027","article-title":"Acetylcholinesterase inhibitors for Alzheimer's disease: anti-inflammatories in acetylcholine clothing","volume":"35","author":"Tabet","year":"2006","journal-title":"Age Ageing"},{"key":"10.1016\/j.neuropharm.2025.110654_bib47","unstructured":"The World HealthOrganization2025. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia."},{"key":"10.1016\/j.neuropharm.2025.110654_bib48","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41573-024-01007-1","article-title":"A golden age of muscarinic acetylcholine receptor modulation in neurological diseases","volume":"23","author":"Tobin","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2025.110654_bib49","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.physbeh.2007.03.025","article-title":"Forty mouse strain survey of water and sodium intake","volume":"91","author":"Tordoff","year":"2007","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2025.110654_bib50","doi-asserted-by":"crossref","first-page":"12787","DOI":"10.1523\/JNEUROSCI.3657-09.2009","article-title":"The \u03b2-Secretase enzyme BACE in health and alzheimer's disease: regulation, cell biology, function, and therapeutic potential","volume":"29","author":"Vassar","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110654_bib51","first-page":"1","article-title":"Autophagy induced by muscarinic acetylcholine receptor 1 mediates migration and invasion targeting Atg5 via AMPK\/mTOR pathway in prostate cancer","volume":"2022","author":"Wang","year":"2022","journal-title":"J. Oncol."},{"key":"10.1016\/j.neuropharm.2025.110654_bib52","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3233\/JAD-150152","article-title":"Acute effects of muscarinic M1 receptor modulation on A\u03b2PP metabolism and Amyloid-\u03b2 levels in vivo: a microdialysis study","volume":"46","author":"Welt","year":"2015","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.neuropharm.2025.110654_bib53","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrd2379","article-title":"Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development","volume":"6","author":"Wess","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2025.110654_bib54","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa058","article-title":"M1 muscarinic acetylcholine receptor dysfunction in moderate Alzheimer's disease pathology","volume":"2","author":"Yi","year":"2020","journal-title":"Brain Commun"},{"key":"10.1016\/j.neuropharm.2025.110654_bib55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/biomedicines7040097","article-title":"Reasons for failed trials of disease-modifying treatments for alzheimer disease and their contribution in recent research","volume":"7","author":"Yiannopoulou","year":"2019","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuropharm.2025.110654_bib56","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3233\/JAD-170246","article-title":"Autophagy-ERK1\/2-Involved disinhibition of hippocampal neurons contributes to the pre-synaptic toxicity induced by A\u03b242 exposure","volume":"59","author":"Yin","year":"2017","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.neuropharm.2025.110654_bib57","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3233\/JAD-2012-120151","article-title":"Novel object recognition as a facile behavior test for evaluating drug effects in A\u03b2PP\/PS1 Alzheimer's disease mouse model","volume":"31","author":"Zhang","year":"2012","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.neuropharm.2025.110654_bib58","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.06734","article-title":"G-protein-coupled receptors regulate autophagy by ZBTB16-mediated ubiquitination and proteasomal degradation of Atg14L","volume":"4","author":"Zhang","year":"2015","journal-title":"eLife"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825003624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825003624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T22:16:46Z","timestamp":1772835406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825003624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":58,"alternative-id":["S0028390825003624"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110654","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Positive allosteric modulation of M1 mAChRs with VU0486846 reverses cognitive deficits in male APPswe\/PSEN1\u0394E9 alzheimer's mice","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110654","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110654"}}